Device Trial Radar · NCT03640793
Prospective Evaluation of a Palato-Pharyngeal Implant System (PPIS) Obstructive Sleep Apnea Syndrome (OSAS)
Last checked: Nov 20, 2026Latest source record: Mar 13, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
25
Actual
Start
Oct 9, 2017
Primary completion
Feb 13, 2024
Study completion Mar 4, 2024
Sponsor
- Lead sponsor
- Medartis AGNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 21, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective Evaluation of a Palato-Pharyngeal Implant System (PPIS) for the Treatment of Snoring and Obstructive Sleep Apnea Syndrome (OSAS): A Pilot Study.
Conditions
- Snoring
- Obstructive Sleep Apnea
Interventions
ImplantationDevice
Implantation of 6 PPIS implants
Primary outcomes
What the sponsor says the trial is designed to measure.
- AHI reductionTime frame: 3 months post-op
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Kantonsspital Liestal
Basel, Basel-Landschaft, Switzerland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.